(NASDAQ:PMN), Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that its board of directors has determined to effect a one-for-twenty-five reverse stock split of the Company's common shares, no par value per share […]
(NYSE:ANVS), MALVERN, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced two presentations at the 18th Clinical Trials on Alzheimer's Disease (CTAD) conference, taking place
(NASDAQ:IPST), GIG HARBOR, Wash., Nov. 24, 2025 (GLOBE NEWSWIRE) — IP Strategy (Nasdaq: IPST) (the “Company”), the first Nasdaq-listed entity operating a digital asset treasury strategy centered on the $IP token, today announced that the webcast replay, investor presentation and transcript from its inaugural Investor Day 2025 are now available on the Investor Relations section
(NASDAQ:MDCX), PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) — November is Men's Health Awareness Month, a time to spotlight the latest medical breakthroughs that may transform how we detect and treat cancer- especially prostate and skin cancer, which are among the most common cancers affecting men. In advanced prostate cancer, lifelong treatment modalities are making a
Washington, D.C., Nov. 24, 2025 (GLOBE NEWSWIRE) — Bestselling author and technology analyst James Altucher says new information shared with him from a private contact inside a closed-door meeting points to a massive shift in how global internet service will work — a shift he believes Elon Musk has been quietly engineering for years. According
(NASDAQ:DARE), SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — DareÌ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that it has received an approximately $3.6 million payment under an existing grant agreement with the Gates Foundation. This
(NASDAQ:MNST), CORONA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) announced today that its Chief Executive Officer, Hilton Schlosberg (the “CEO“), and members of its senior executive team will host an investor meeting Tuesday, December 2, 2025, to provide an update on the Company's business and operations. The Company's presentation will
(NASDAQ:CDTX), Target enrollment of 6,000 participants completed in the Northern Hemisphere Planned interim analysis in Q1 2026 will determine potential need for additional enrollment during Southern Hemisphere flu season SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC)
(NYSE:ANF), NEW ALBANY, Ohio, Nov. 24, 2025 (GLOBE NEWSWIRE) — Hollister Co. (“Hollister”), a brand of Abercrombie & Fitch Co. (NYSE: ANF), and Taco Bell are heating up the holidays with a limited-edition collaboration that delivers equal parts cozy and nostalgic. Launching on Dec. 1, the Y2K-inspired capsule collection fuses Hollister's classic Feel Good Fleece
(NASDAQ:ITRM), DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now